Neuropeptides

PE-22-28

Spadin-derived TREK-1 channel blocker, 10mg vial

$59.00

Format Lyophilized powder, vial
Purity ≥99% (HPLC)
CAS 1801959-12-5
Documentation COA by request

This product is intended for in-vitro and pre-clinical research purposes only. It is not intended for human consumption, nor for use as a drug, food additive, or household chemical. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges all risks of handling and distribution, and agrees to indemnify Sokai Sciences against any claims arising from misuse.

FAQ

Common questions

What is PE-22-28?+

A synthetic peptide derived from spadin, a fragment of the sortilin propeptide, studied as a TREK-1 channel blocker.

What research area is PE-22-28 associated with?+

Antidepressant-mechanism research literature, specifically TREK-1 channel pharmacology.

What CAS number identifies PE-22-28?+

1801959-12-5.

About

About PE-22-28

PE-22-28 is a synthetic peptide derived from spadin, a fragment of the sortilin propeptide, studied in the literature as a TREK-1 potassium-channel blocker within antidepressant-mechanism research. Third-party HPLC-verified purity (≥99% (HPLC)). For laboratory research use only.